Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
...
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
...
polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors
Roots Analysis is pleased to announce the publication of its recent study, titled, “Polycystic Ovary Syndrome Market, 2021-2031.”
The report features an...
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker,...
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies,...
Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are not only safe and efficient, but also promote therapy adherence
London
Roots Analysis has announced the addition of “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and...
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios...
Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic
Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings
The report features an in-depth analysis,...
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions
London
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to...
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”.
The...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)